Sales : +91-777 804 8217
| Sr No | Corrigendum Date | Corrigendum | Type | New Submission Date |
|---|---|---|---|---|
| 1 | 10-01-2024 | 18-01-2024 | ||
| 2 | 28-12-2023 | 11-01-2024 |
| Sl. No. | Item Title | |
| 1 | Jacobsen syndrome (JBS) | |
| 2 | JAK2 PANEL | |
| 3 | JAK2 V617F mutation by PCR | |
| 4 | JAK2 V617F mutation by Sanger | |
| 5 | JAK2 V617F with reflex to Exon 12 | |
| 6 | JC virus Qualitative | |
| 7 | Jo-1 ANTIBODY | |
| 8 | Joubert and Meckel-Gruber Syndromes Panel-18 genes | |
| 9 | Joubert Syndrome (JBTS) Panel | |
| 10 | Juvenile Polyposis Syndrome - BMPR1A, SMAD4 | |
| 11 | Juvenile polyposis syndrome (JPS) | |
| 12 | Kabuki Syndrome (KABUK) Panel | |
| 13 | Kabuki Syndrome Panel - KDM6A, KMT2D | |
| 14 | Kallmann syndrome 1 (KAL1) | |
| 15 | Kappa Light Chain | |
| 16 | KARYOTYPE - AMNIOTIC FLUID | |
| 17 | KARYOTYPE - Bone Marrow | |
| 18 | KARYOTYPE - PERIPHERAL BLOOD (Couple) | |
| 19 | KARYOTYPE - PERIPHERAL BLOOD (Husband) | |
| 20 | KARYOTYPE - PERIPHERAL BLOOD (SINGLE) | |
| 21 | KARYOTYPE - PRODUCTS OF CONCEPTION | |
| 22 | KARYOTYPE CHORIONIC VILLUS SAMPLING | |
| 23 | KARYOTYPE PERIPHERAL BLOOD FOR HEMATOLOGICAL MALIGNANCY | |
| 24 | Ki 67 (IHC Marker) | |
| 25 | KIT and PDGFRA mutation panel | |
| 26 | KIT mutations | |
| 27 | Kleefstra syndrome | |
| 28 | Klinefelter syndrome | |
| 29 | KOH Examination For CSF | |
| 30 | KOH Preparation For Fungus | |
| 31 | Koolen-De Vries syndrome (KDVS) | |
| 32 | Krabbe Disease Test - GALC | |
| 33 | L1 syndrome | |
| 34 | Lacosamide Level | |
| 35 | Lactate Level | |
| 36 | Lactate Level (CSF) | |
| 37 | Lambda Light Chain | |
| 38 | Lamotrigine Level | |
| 39 | LAP Score | |
| 40 | LBC PAP + PCR HPV DNA | |
| 41 | LBC PAP SMEAR | |
| 42 | LDH Fluid | |
| 43 | LDH Isoenzymes | |
| 44 | LDH Serum | |
| 45 | LDL Cholesterol (Direct) | |
| 46 | Lead Urine Spot | |
| 47 | Lead Level | |
| 48 | LEAD LEVEL IN LIVER BIOPSY | |
| 49 | Left Ventricular Noncompaction Panel (LVNC): ACTC1, DSP, HCN4, LAMP2, LM NA, MYBPC3, MYH7PLN, RYR2, SCN5A, TAZ, TNNI3, TNNT2, TP M1, VCL, DTNA, LDB3, PRDM16 | |
| 50 | LFT- Liver Function Test (SGPT, SGOT, Billirubin Total and Direct, Alkaline Phosphatase, Total Protein, Albumin, Globulin, AG ratio) | |
| 51 | Legionella IgM | |
| 52 | Legionella Pneumophila Ag Urine | |
| 53 | Legionella Urinary Antigen | |
| 54 | Leigh Syndrome - NDUFS8 | |
| 55 | Leigh syndrome (LS) | |
| 56 | Leigh syndrome, X-linked | |
| 57 | Leismania IgG (Ho) | |
| 58 | LEISMANIA IGM (HO) | |
| 59 | LEPTIN SERUM | |
| 60 | Leptospira By PCR | |
| 61 | Leptospira Detection by smear examination | |
| 62 | Leptospira IgG | |
| 63 | Leptospira IgM | |
| 64 | Leri-Weill dyschondrosteosis (LWD) | |
| 65 | Lesch-Nyhan syndrome (LNS) | |
| 66 | LEUCOCYTE ADHESION DEFECT (LAD) | |
| 67 | Leukodystrophy, demyelinating, adult onset, autosomal dominant (ADLD) | |
| 68 | Levetiracetam | |
| 69 | LH | |
| 70 | Li-Fraumeni Syndrome - TP53 | |
| 71 | Ligase IV Syndrome Test - LIG4 | |
| 72 | Limb-Girdle Muscular Dystrophy Panel - 31 genes | |
| 73 | Lipase | |
| 74 | Lipase Fluid | |
| 75 | Lipid Profile | |
| 76 | Lipoprotein (a) | |
| 77 | Liquid biopsy-Somatic cancer panel | |
| 78 | Liquid EGFR | |
| 79 | Lissencephaly (LIS) Panel | |
| 80 | Lissencephaly, X-linked (LISX) Panel | |
| 81 | Lithium | |
| 82 | LIVER PROFILE BY IMMUNOBLOT | |
| 83 | LKM 1 Antibody By IF | |
| 84 | LKM Antibodies ELISA | |
| 85 | Loeys-Dietz Syndrome Panel- SMAD3, TGFB2, TGFBR1, TGFBR 2, FBN1, TGFB3 | |
| 86 | Long QT Syndrome Panel - AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1, SCN4B, SCN5A, SNTA1 | |
| 87 | Lowe oculocerebrorenal syndrome (OCRL) | |
| 88 | Lp (A) (Lipoprotein A) | |
| 89 | Lubs X-linked mental retardation syndrome (MRXSL) | |
| 90 | Lujan Syndrome Test - MED12 | |
| 91 | Lung Adenocarcinoma - BRAF | |
| 92 | Lung Adenocarcinoma - EGFR by ARMS PCR | |
| 93 | Lung Adenocarcinoma - EGFRby Sanger | |
| 94 | Lung Adenocarcinoma - KRAS | |
| 95 | Lung cancer panel-somatic mutations (EGFR, KRAS, BRAF) | |
| 96 | LUNG CANCER TARGETED GENE PANEL (EGFR KRAS BRAF MET ERBB2 ALK1 ROS1) | |
| 97 | Lupus Anticoagulant (LA) | |
| 98 | LYME DISEASE ( BORRELIA BURGDORFERI IgM & IgG ) | |
| 99 | Lymphocyte Subset Analysis | |
| 100 | Lymphoproliferative syndrome, X-linked, 1 (XLP1) | |
| 101 | Lynch Syndrome - MLH1, MSH2, MSH6, PMS2 (offered as single gene if there is a KFM or if there?s IHC negative staining) | |
| 102 | Lynch syndrome panel - EPCAM, MLH1, MSH2, MSH6, MUTYH, PMS2 | |
| 103 | Macrocephaly/autism syndrome | |
| 104 | Magnesium | |
| 105 | Magnesium 24 Hour Urine | |
| 106 | Magnesium Urine spot | |
| 107 | Malaria Parasites | |
| 108 | Malarial Antigen (Rapid Card) Test | |
| 109 | Malignant Hyperthermia Susceptibility Panel- CACNA1S, RYR1 | |
| 110 | Mandibulofacial dysostosis, Guion-Almeida type | |
| 111 | Manganese Level | |
| 112 | Maple Syrup Urine Disease Panel-BCKDHA, BCKDHB, DBT | |
| 113 | Marfan syndrome (MFS) | |
| 114 | MCAD Common Mutation Analysis-ACADM | |
| 115 | MDR And XDR | |
| 116 | MDR AND XDR - TB RAPID GENOTYPING TEST | |
| 117 | MDR TB RAPID GENOTYPING TEST 1ST LINE (INH & RIFAMPICIN) LPA | |
| 118 | MDR TB Rapid Genotyping Test 1st Line(Inh And Rifampicin) | |
| 119 | MDS KT+FISH PANEL (Karyotyping FISH del 5q del 7q del 20q CEP 8) | |
| 120 | Measels (Rubeola) Antibody IgG | |
| 121 | Measels (Rubeola) Antibody IgM | |
| 122 | Measles (Rubeola) IgG Antibody | |
| 123 | Melanoma Panel - 11 genes | |
| 124 | Melanoma-Pancreatic Cancer Syndrome Panel -CDK4, CDKN2A | |
| 125 | Meningitis (Viral) Profile IgG & IgM by CLIA | |
| 126 | Mercury Blood By ICPMS | |
| 127 | Metabolic Disorder Panel | |
| 128 | Metabolic Study For Stone | |
| 129 | Metachondromatosis (METCDS) | |
| 130 | Metachromatic Leukodystrophy Test -ARSA, ASPA, GALC, HEXA, HEXB | |
| 131 | Metachromatic leukodystrophy (MLD) | |
| 132 | Metagenome_DB (Metagenome Genome Database) | |
| 133 | Metanephrine - Free Plasma | |
| 134 | Metanephrine 24 Hour Urine | |
| 135 | Metatranscriptome Sequencing & Analysis | |
| 136 | Meth Haemoglobin | |
| 137 | Methionine | |
| 138 | Methotrexate | |
| 139 | Methyl Malonic Acid Qualitative,Urine | |
| 140 | METHYLMALONIC ACID QUANTITATIVE SERUM | |
| 141 | Methylmalonic Acidemia Panel - MMAA, MMAB, MMACHC, MM ADHC, MUT | |
| 142 | MGMT methylation test | |
| 143 | MIC by E strip | |
| 144 | Micophthalmia, Syndromic (MCOPS) Panel | |
| 145 | Microalbumin | |
| 146 | Microalbumin/Creatinine Ratio Urine | |
| 147 | Microarray - Product of conception | |
| 148 | Microarray 315K | |
| 149 | Microarray 315K Prenatal With MCC | |
| 150 | Microarray 750K | |
| 151 | Microarray 750K Prenatal With MCC | |
| 152 | Microbial Identification Contig (MID-C) | |
| 153 | Microbial Identification Report (MID-R) | |
| 154 | Microbial Identification Sequence (MID-S) | |
| 155 | Microfilaria Antibody by card | |
| 156 | MICROFILARIA BY PS | |
| 157 | Microfilaria By Smear | |
| 158 | Microfilaria Detection By Card | |
| 159 | Microsatellite (Per well tube/reaction) (SAMPLE-4) | |
| 160 | Microsatellite instability (MSI) | |
| 161 | Microvascular complications of diabetes 1 (MVCD1) | |
| 162 | Miller-Dieker lissencephaly syndrome (MDLS) | |
| 163 | Minimal Residual Disease By Flow Cytometry | |
| 164 | Mitochondrial disease panel (37 genes) | |
| 165 | MLL (mixed lineage leukemia gene (MLL) | |
| 166 | MLST-01 (Multilocus sequence Typing (MLST) | |
| 167 | MM FISH and Karyotyping Panel | |
| 168 | MM FISH Panel | |
| 169 | MODIFIED ACID FAST STAIN | |
| 170 | Modified ZN Stain | |
| 171 | MOG PANEL | |
| 172 | MOG with NMO PANEL CSF | |
| 173 | MOG WITH NMO Panel Seum | |
| 174 | Mohr-Tranebjaerg syndrome (MTS) | |
| 175 | Monomeric Prolactin | |
| 176 | Monomeric Prolactin (Active Prolactin) | |
| 177 | Mowat-Wilson syndrome (MOWS) | |
| 178 | Mp By Card Method | |
| 179 | MPL W 515/S 505 Mutation Analysis | |
| 180 | MS-MLPA | |
| 181 | MTB PCR | |
| 182 | MTB/NTM PCR | |
| 183 | MTB-MDR (RIF/INH) | |
| 184 | MTB-XDR (Fluoroquinolones/ Injectable drugs) | |
| 185 | MTHFR by PCR | |
| 186 | MTHFR by Sanger | |
| 187 | Mucopolysaccharides (MPS) qualitative Urine | |
| 188 | Mucopolysaccharides (Mps) Screen | |
| 189 | Mucopolysaccharides (MPS) typing | |
| 190 | Mucopolysaccharidosis Type 3 (MPS 3) Panel | |
| 191 | Mucopolysaccharidosis type II (MPS2) | |
| 192 | Mucopolysaccharidosis Type II Test - IDS | |
| 193 | MUCOR RACEMOSUS - SPECIFIC IGG | |
| 194 | Multi-Cancer Panel - 79 genes | |
| 195 | Multiminicore Disease Panel- RYR1, SEPN1 | |
| 196 | Multiple Carboxylase Deficiency Panel -BTD, HLCS | |
| 197 | Multiple Endocrine Neoplasia, Type 1-MEN1 | |
| 198 | Multiple Endocrine Neoplasia, Type 2-RET | |
| 199 | MULTIPLE MYELOMA FISH PANEL(DEL13q t(4;14) t(11;14) t(14;16) DEL17p) | |
| 200 | Multiplex PCR (15,17) (11,17)(5,17) for AML | |
| 201 | Mumps Antibody IgG | |
| 202 | Mumps Antibody IgM | |
| 203 | Muscular dystrophy, Duchennetype (DMD) | |
| 204 | MUSTISHK STROKE PANEL | |
| 205 | MUTYH-associated Polyposis (targeted) | |
| 206 | Mycoplasma Pneumonia IgG | |
| 207 | Mycoplasma Pneumonia IgM | |
| 208 | MYCOXPERT | |
| 209 | Myelodysplastic Syndrome/Leukemia Panel - 21 genes | |
| 210 | Myofibrillar Myopathy Panel- BAG3, CRYAB, DES, DNAJB6, FH L1, FLNC, LDB3, MYOT | |
| 211 | Myoglobin Serum | |
| 212 | Myotonia and Paramyotonia Congenita panel (2 genes) | |
| 213 | Myotonic Dystrophy Type-1 | |
| 214 | Myotonic Dystrophy Type-2 | |
| 215 | Myotubular myopathy, X-linked (CNMX) | |
| 216 | Nablus mask-like facial syndrome (NMLFS) | |
| 217 | Nail-patella syndrome (NPS) | |
| 218 | Nance-Horan syndrome (NHS) | |
| 219 | Nemaline Myopathy Panel - 10 genes | |
| 220 | Nephronophthisis 1 (NPHP1) | |
| 221 | Nephronophthisis Panel-12genes | |
| 222 | Nervous System/Brain Cancer Panel -39 genes | |
| 223 | NEUGEN IHC MARKER | |
| 224 | Neurodegenration with Brain Iron Accumulation Panel (upto 14 genes) | |
| 225 | Neurofibromatosis Type 1 Test - NF1 | |
| 226 | Neurofibromatosis Type 2 Test - NF2 | |
| 227 | Neuronal Ceroid Lipofuscinoses Panel- CLN3, CLN5, CLN6, CLN8, CTSD, DNAJC5, KCTD,7MFSD8, PPT1, TPP1 | |
| 228 | Neuropathy, Hereditary, with liability to pressure palsies (HNPP) | |
| 229 | Neurotropic Virus panel | |
| 230 | NGAL (NETROPHIL GELATINASE ASSOCIATED LIPOCALIN) URINE | |
| 231 | NGS Glycogen Storage Disease Comprehensive Panel | |
| 232 | NGS Mucopolysaccharidoses (MPS) Comprehensive Panel | |
| 233 | NGS Muscular Dystrophy Comprehensive Panel | |
| 234 | NGS Myopathy Comprehensive Panel | |
| 235 | NGS DKC1 Dyskeratois congenita and Shwachman -Diamond SDBS | |
| 236 | NGS 161 gene OCAV3 Assay ( DNA mutations CNVs RNA Fusions) | |
| 237 | NGS 409 gene Mutation Screening (SNV INDEL) + TMB | |
| 238 | NGS 546 Gene Oncomine Comprehensive Assay Plus (DNA mutations CNVs RNA Fusions MSI TMB HRR) | |
| 239 | NGS Achromatopsia Cone and Cone-rod Dystrophy | |
| 240 | NGS Adult Refsum Disease | |
| 241 | NGS Aicardi-Goutieres syndrome | |
| 242 | NGS Albinism | |
| 243 | NGS Alkaptonuria | |
| 244 | NGS Alport syndrome | |
| 245 | NGS Alzheimer Dementia and Dementia | |
| 246 | NGS Amyotrophic Lateral Sclerosis (ALS) | |
| 247 | NGS Arrhythmia Comprehensive Panel | |
| 248 | NGS Arrhythmogenic Cardiomyopathy | |
| 249 | NGS Arthrogryposis | |
| 250 | NGS Autism Panel | |
| 251 | NGS Bardet Biedl | |
| 252 | NGS Barter Syndrome | |
| 253 | NGS Biotinidase Deficiency | |
| 254 | NGS B-negative SCID | |
| 255 | NGS BONE MARROW FAILURE SYNDROME GENE PANEL | |
| 256 | NGS B-positive SCID | |
| 257 | NGS Brain Iron Accumulation Syndromes | |
| 258 | NGS Brain Malformations Comprehensive Panel | |
| 259 | NGS BRCA 1 & 2 with deletions/Duplications (Germline) (NGS + MLPA) | |
| 260 | NGS BRCA1 & 2 (Germline)Assay | |
| 261 | NGS BRCA1 & 2 (Somatic)Assay | |
| 262 | NGS Breast Cancer | |
| 263 | NGS Brugada syndrome | |
| 264 | NGS CAH Deletion & Duplication Detection | |
| 265 | NGS Canavan Disease | |
| 266 | NGS Cancer 12 Gene Panel | |
| 267 | NGS Cancer hot spot V2 Panel (50 gene mutations) | |
| 268 | NGS Cancer Comprehensive Panel | |
| 269 | NGS Cardiomyopathy and Skeletal Muscle Disease | |
| 270 | NGS Cardiomyopathy Comprehensive Panel | |
| 271 | NGS Cardiomyopathy | |
| 272 | NGS Cerebellar Ataxia | |
| 273 | NGS Ceroid Lipofuscinosis | |
| 274 | NGS Charcot Marie Tooth Disease | |
| 275 | NGS Childhood-Onset Epilepsy | |
| 276 | NGS Ciliopathies | |
| 277 | NGS Combined Hereditary Dementia and Amyotrophic Lateral Sclerosis | |
| 278 | NGS Combined Mito Genome Plus Mito Nuclear Gene | |
| 279 | NGS Congenital Adrenal Hyperplasia | |
| 280 | NGS Congenital Diserythropoetic Anaemia | |
| 281 | NGS Congenital Disorders of Glycosylation | |
| 282 | NGS Congenital Muscular Dystrophy | |
| 283 | NGS Congenital Myasthenic Syndrome | |
| 284 | NGS Congenital Myopathy | |
| 285 | NGS Congenital Neutropenia | |
| 286 | NGS Cornelia de Lange syndrome | |
| 287 | NGS Cortical Brain Malformations? | |
| 288 | NGS Cystic Fibrosis complete gene sequencing (CFTR GENE) | |
| 289 | NGS Cystinosis | |
| 290 | NGS Cystinuria | |
| 291 | NGS DBA (Diamond Blackfan Anaemia) | |
| 292 | NGS Deafness Non-syndromic Sensorineural Autosomal Dominant | |
| 293 | NGS Deafness Non-syndromic Sensorineural Autosomal Recessive | |
| 294 | NGS Dilated Cardiomyopathy | |
| 295 | NGS DMD carrier deletion/duplication testing by MLPA | |
| 296 | NGS DNA Extraction and Storage for 5 years | |
| 297 | NGS Dystonia | |
| 298 | NGS Early Infantile Epileptic Encephalopathy | |
| 299 | NGS Epilepsy Comprehensive Panel | |
| 300 | NGS Episodic Ataxia | |
| 301 | NGS Eye Disorders: Comprehensive Panel | |
| 302 | NGS Fabry Disease | |
| 303 | NGS Familial HLH(Hemophagocytic Lymphohistiocytosis) | |
| 304 | NGS Familial Mediterranean Fever | |
| 305 | NGS Fanconi Anaemia | |
| 306 | NGS Fatty Acid Oxidation Defects | |
| 307 | NGS Female Infertility | |
| 308 | NGS Flecked-retina Disorders | |
| 309 | NGS for Hereditary Hemolytic Anemia (Membranopathy and Enzymopathy) | |
| 310 | NGS Galactosemia | |
| 311 | NGS GENE PANEL TEST | |
| 312 | NGS Glucose-6-Phosphate Dehydrogenase Deficiency | |
| 313 | NGS Glutaric Acidemia Type I | |
| 314 | NGS Glycine Encephalopathy | |
| 315 | NGS GM2 Gangliosidosis | |
| 316 | NGS Hemochromatosis HFE Full Gene Sequencing | |
| 317 | NGS Hemophilia A and B(Factor VIII and Factor IX) | |
| 318 | NGS HEREDITARY CANCER PANEL (GERMLINE) | |
| 319 | NGS Hereditary cancer panel with BRCA 1&2 Deletions/Duplications (NGS + MLPA) | |
| 320 | NGS Hereditary Hemochromatosis | |
| 321 | NGS Hereditary hemorrhagic telangiectasia | |
| 322 | NGS Hereditary Neuropathy Sequencing | |
| 323 | NGS Hereditary Parkinson?s Disease & Parkinsonism | |
| 324 | NGS hereditary Spastic Paraplegia | |
| 325 | NGS Hereditary Thrombophilia | |
| 326 | NGS HIGH RESOLUTION HLA TYPING | |
| 327 | NGS HIGH RESOLUTION HLA TYPING (HISTOGENETICS) | |
| 328 | NGS Homocystinuria | |
| 329 | NGS HRD Gene Panel | |
| 330 | NGS HRR Gene Panel | |
| 331 | NGS Hyper-IgE Syndromes | |
| 332 | NGS Hyperphenylalaninemia | |
| 333 | NGS Hyperprolinemia | |
| 334 | NGS Hypertrophic Cardiomyopathy | |
| 335 | NGS Infantile Epilepsy | |
| 336 | NGS Joubert and Meckel-Gruber Syndromes | |
| 337 | NGS Krabbe Disease | |
| 338 | NGS Limb Malformation: Sequencing | |
| 339 | NGS Limb-Girdle Muscular Dystrophy: Sequencing | |
| 340 | NGS Lissencephaly | |
| 341 | NGS Liver Glycogen Storage Disease | |
| 342 | NGS Long QT Syndrome | |
| 343 | NGS lung Cancer 12 Gene panel | |
| 344 | NGS Lysosomal Storage Disorders Comprehensive Panel | |
| 345 | NGS Macular Dystrophy/DeGeneration/Stargardt Disease | |
| 346 | NGS Male Ifertility | |
| 347 | NGS Maple Syrup Urine Disease | |
| 348 | NGS Marfan Syndrome | |
| 349 | NGS Maternal Cell Contamination | |
| 350 | NGS Metachromatic Leukodystrophy | |
| 351 | NGS Microphthalmia/Anophthalmia/Coloboma Spectrum | |
| 352 | NGS Mitochondrial Encephalopathy/ Leigh Syndrome Nuclear Gene | |
| 353 | NGS Mitochondrial Nuclear Gene Comprehensive Panel | |
| 354 | NGS MODY Panel | |
| 355 | NGS Mucolipidosis | |
| 356 | NGS Myoclonic Dystonia | |
| 357 | NGS Nephrotic Syndrome Gene Panel | |
| 358 | NGS Neuromuscular Disorders Comprehensive Panel | |
| 359 | NGS Neuropathies Comprehensive Panel | |
| 360 | NGS Neurotransmitter Disorders | |
| 361 | NGS Niemann-Pick Disease Types A and B | |
| 362 | NGS Niemann-Pick Type C | |
| 363 | NGS Non ketotic hyperglycinemia | |
| 364 | NGS Noonan and RASopathies | |
| 365 | NGS Obesity Panel | |
| 366 | NGS Omixome Duos (CES+MtDNA+CNV) | |
| 367 | NGS Omixome Solo (CES+MtDNA+CNV) | |
| 368 | NGS Omixome Trios (CES+MtDNA+CNV) | |
| 369 | NGS Oncomine cfTNA Lung assay (DNA+RNA) | |
| 370 | NGS Oncomine cfTNA Pan Cancer assay (DNA+RNA) | |
| 371 | NGS Oncomine Focus Assay (52 genes DNA mutations CNVs RNA Fusions) | |
| 372 | NGS Oncomine Myeloid V2 GX DNA only Assay | |
| 373 | NGS Oncomine Myeloid V2 GX RNA only Assay | |
| 374 | NGS Oncomine Myeloid V2GX Assay | |
| 375 | NGS Oncomine Precison GX Assay (DNA mutations CNVs RNA Fusions)(Liquid biopsy) | |
| 376 | NGS Oncomine Precison GX Assay (DNA mutations CNVs RNA Fusions) | |
| 377 | NGS Oncomine Tumour mutation burden | |
| 378 | NGS Organic Acidemias | |
| 379 | NGS Overgrowth and Macrocephaly Syndromes | |
| 380 | NGS Periodic Fever Syndromes | |
| 381 | NGS Polycystic kidney | |
| 382 | NGS Pompe Disease | |
| 383 | NGS Pontocerebellar hypoplasia | |
| 384 | NGS Premature Ovarian Failure: Sequencing and FMR1 CGG Repeat Analysis | |
| 385 | NGS Prenatal Noonan Spectrum Disorders | |
| 386 | NGS Prenatal Omixome(CES+MtDNA+CNV) + MCC | |
| 387 | NGS Prenatal UniExome(Whole Exome +MtDNA+CNV) + MCC | |
| 388 | NGS Primary hyperoxiluria | |
| 389 | NGS PRIMARY IMMUNODEFICIENCY GENE PANEL | |
| 390 | NGS Progressive External Ophthalmoplegia (PEO)/Optic Atrophy Nuclear Genes | |
| 391 | NGS Progressive Myoclonic Epilepsy | |
| 392 | NGS Propionic Acidemia | |
| 393 | NGS Pulmonary Disease: Comprehensive Panel | |
| 394 | NGS Pulmonary Fibrosis and Hermansky-Pudlak Syndrome | |
| 395 | NGS Pulmonary Hypertension | |
| 396 | NGS Reanalysis and Reinterp (panel exome) | |
| 397 | NGS Retina/Photoreceptor Dystrophy | |
| 398 | NGS Retinitis Pigmentosa | |
| 399 | NGS Rhizomelic Chondrodysplasia Punctata Spectrum | |
| 400 | NGS Sandhoff Disease | |
| 401 | NGS SCID Comprehensive Panel | |
| 402 | NGS Segregation analysis for 2 mutations in one patient | |
| 403 | NGS Segregation Analysis one mutation for two family members | |
| 404 | NGS Segregation Analysis Only per mutation per person | |
| 405 | NGS Short QT Syndrome | |
| 406 | NGS Single Gene (SNV+CNV) | |
| 407 | NGS Skeletal Dysplasia With Increased Bone Density | |
| 408 | NGS SMA by MLPA | |
| 409 | NGS SMA carrier testing by MLPA | |
| 410 | NGS Sudden Cardiac Arrest (SCA) | |
| 411 | NGS Tay-Sachs Disease | |
| 412 | NGS Treachers Collins Syndrome | |
| 413 | NGS Tuberous Sclerosis | |
| 414 | NGS Typical and Atypical HUS | |
| 415 | NGS Tyrosinemia | |
| 416 | NGS Unicad NIPT 5 chromosomes | |
| 417 | NGS UniExome Duos (Whole Exome +MtDNA+CNV) | |
| 418 | NGS UniExome Solo (Whole Exome +MtDNA+CNV) | |
| 419 | NGS UniExome Trios(Whole Exome +MtDNA+CNV) | |
| 420 | NGS UniFusion Seq Assay | |
| 421 | NGS UniPanel(Ask us for customized Panel) SNV+CNV | |
| 422 | NGS Urea Cycle Disorders | |
| 423 | NGS Usher Syndrome | |
| 424 | NGS Waardenburg Syndrome | |
| 425 | NGS Wilson Disease | |
| 426 | NGS X linked Thrombocytopenia | |
| 427 | NGS Zellweger Spectrum Disorder | |
| 428 | NGS Zellweger syndrome | |
| 429 | Nicotine Level / Cotinine Level (Urine) | |
| 430 | Nicotine Metabolite, Serum | |
| 431 | Niemann-Pick Type C Panel - NPC1, NPC2 | |
| 432 | Nijmegen Breakage Syndrome Test | |
| 433 | NK Cell (CD16 + CD56) | |
| 434 | NK CELL (CD16 + CD56) | |
| 435 | NMDA ANTIBODY CSF | |
| 436 | NMDA Antibody Serum | |
| 437 | NMDA Receptor Antibody (NR1) | |
| 438 | NMO with MOG Antibody Profile for CSF | |
| 439 | Nocardia culture | |
| 440 | Non-invasive prenatal testing (NIPT) | |
| 441 | Noonan Syndrome (NS) Panel | |
| 442 | Noonan Syndrome Panel- A2ML1, BRAF, CBL, KRAS, MAP2 K1, MAP2K2, NRAS,PTPN11, RA F1, RIT1, SHOC2, SOS1, ACTB | |
| 443 | Noonan Syndrome with Multiple Lentigines Panel - BRAF, PTPN11, RAF1 | |
| 444 | Nor Metanephrine - Free Plasma | |
| 445 | Nor-Metanephrine 24 Hour Urine | |
| 446 | NOTCH3 Mutations | |
| 447 | NPM1 (nucleophosmin gene (NPM1) | |
| 448 | NRAS (neuroblastoma RAS viral oncogene homolog) | |
| 449 | NS 1 DENGUE ANTIGEN (Rapid) | |
| 450 | NSE - Neuron Specific Enolase | |
| 451 | NSE Serum | |
| 452 | NT- proBNP | |
| 453 | Nystagmus, infantile periodic alternating, X-linked (NYS1) | |
| 454 | Obesity, severe | |
| 455 | Occipital horn syndrome (OHS) | |
| 456 | Occult Blood -Stool | |
| 457 | Oculacutaneous Albinism, type II (OCA2) | |
| 458 | Oculo-Facio-Cardio-Dental Syndrome Test -BCOR | |
| 459 | Oligoclonal Band CSF | |
| 460 | Oligodontia-Colorectal Cancer Syndrome Test - AXIN2 | |
| 461 | OPA PLUS (NGS Oncomine Precision Assay + sBRCA) | |
| 462 | Opitz GBBB syndrome, X-linked | |
| 463 | Opportunistic Infection Panel | |
| 464 | Oral-Facial-Digital Syndrome, Type 1 Test - OFD1 | |
| 465 | Organic Acidemias Panel-31 genes | |
| 466 | Ornithine transcarbamylase deficiency | |
| 467 | Orofaciodigital syndrome I (OFD1) | |
| 468 | Osmolality Serum | |
| 469 | Osmolality Urine | |
| 470 | OSMOTIC FRAGILITY TEST | |
| 471 | Osteogenesis Imperfecta Panel- COL1A1, COL1A2, CRTAP, P3H1 | |
| 472 | Osteogenesis imperfecta, type II (OI2) | |
| 473 | Osteogenesis imperfecta, type IV | |
| 474 | Otofaciocervical syndrome 1 (OFC1) | |
| 475 | Oxalate 24 Hour Urine | |
| 476 | P1NP | |
| 477 | P1NP (Procollagen Type 1 Amino Terminal Propeptide) Total | |
| 478 | P24 Antigen | |
| 479 | Pallister-Hall syndrome (PHS) | |
| 480 | Pallister-Killian syndrome (PKS) | |
| 481 | P-ANCA (MPO) By ELISA | |
| 482 | PAP Smear staining and reporting | |
| 483 | PAP Smear staining and reporting | |
| 484 | PAP Smear Liquid Based Cytology (LBC) | |
| 485 | Papp-A (Pregnancy-associated plasma protein A) | |
| 486 | PARA NEOPLASTIC PROFILE(NEURONAL ANTIGENS PROFILE) | |
| 487 | Paracetamol | |
| 488 | Parietal foramina 1 (PFM) | |
| 489 | Parvovirus B19 IgG | |
| 490 | Parvovirus B19 IgM | |
| 491 | PARVOVIRUS B19, Qualitative PCR | |
| 492 | PAS (Periodic Acid Schif) Stain | |
| 493 | Patau syndrome | |
| 494 | PATERNITY TEST | |
| 495 | PCR CHLAMYDIA TRACHOMATIS & GONORRHOEAE COMBO PANEL | |
| 496 | PCR GENITAL ULCER DISEASE PANEL | |
| 497 | PCR VIRAL EYE INFECTION PANEL | |
| 498 | PCR ABL KINASE MUTATION FOR IMATINIB RESISTANCE (IRMA) | |
| 499 | PCR ADENO VIRUS - QUALITATIVE | |
| 500 | PCR ADENO VIRUS - QUANTITATIVE | |
| 501 | PCR ADRB2 Genotyping | |
| 502 | PCR Alpha thalassemia complete work-up | |
| 503 | PCR ALPHA THALASSEMIA DELETIONS/DUPLICATION (MLPA) | |
| 504 | PCR Alpha Thalassemia Sequencing | |
| 505 | PCR AML1/ETO t(8:21) | |
| 506 | PCR APC GENE MUTATION - FAMILY SCREENING | |
| 507 | PCR APC GENE MUTATION - PATIENT | |
| 508 | PCR Aspergillus Spp. Detection | |
| 509 | PCR B CELL RECEPTOR GENE REARRANGEMENT | |
| 510 | PCR BACTERIAL IDENTIFICATION (CLINICAL SAMPLE) | |
| 511 | PCR Basic Colorectal Cancer Panel A (KRAS NRAS BRAFV600E MSI) | |
| 512 | PCR Basic Colorectal Cancer Panel B (KRAS NRAS BRAFV600E) | |
| 513 | PCR BCR ABL MINOR QUANTITATIVE (p190) | |
| 514 | PCR BCR ABL(IS) QUANTITATIVE (p210) | |
| 515 | PCR BCR/ABL QUALITATIVE MAJOR (p210) | |
| 516 | PCR BCR/ABL QUALITATIVE MINOR (p190) | |
| 517 | PCR BCR-ABL1 QUALITATIVE (p190 p210 & p230) | |
| 518 | PCR Beta Thalassemia | |
| 519 | PCR Beta thalassemia complete work-up | |
| 520 | PCR BK Virus (QUALITATIVE) | |
| 521 | PCR BK Virus (QUANTITATIVE) | |
| 522 | PCR BRAF V600E MUTATION | |
| 523 | PCR C KIT gene mutation (exon 9 11 13 17) (Gist/Melanoma) | |
| 524 | PCR CAL R MUTATION | |
| 525 | PCR CBFB/MYH11 FOR INV16 | |
| 526 | PCR CEBPA MUTATION | |
| 527 | PCR chikungunya and dengue (Qualitative) | |
| 528 | PCR Chikungunya RNA (Qualitative) | |
| 529 | PCR Chikungunya RNA (Quantitative) | |
| 530 | PCR CHIMERISM - FOLLOW UP SAMPLE ( POST-TRANSPLANT PATIENT) | |
| 531 | PCR CHIMERISM (SINGLE SAMPLE) | |
| 532 | PCR CHLAMYDIA TRACHOMATIS | |
| 533 | PCR C-KIT AML (Exon 8 17) | |
| 534 | PCR CMV - URINE | |
| 535 | PCR CMV (QUALITATIVE) | |
| 536 | PCR CMV QUANTITATIVE | |
| 537 | PCR COVID 19 | |
| 538 | PCR CXCR4 Mutation Testing | |
| 539 | PCR CYP2C*19 (CLOPIDOGREL) | |
| 540 | PCR CYP3A5 GENOTYPING | |
| 541 | PCR CYSTIC FIBROSIS | |
| 542 | PCR DELTA-BETA THALASSEMIA | |
| 543 | PCR Dengue (Qualitative) | |
| 544 | PCR Dengue (Quantitative) | |
| 545 | PCR DENGUE TYPING | |
| 546 | PCR DNMT3A MUTATION | |
| 547 | PCR DPD GENE MUTATION | |
| 548 | PCR DUCHENNE / BECKER MUSCULAR DYSTROPHY (DMD/BMD) | |
| 549 | PCR E2/PBX1 t(1;19) | |
| 550 | PCR EBV QUALITATIVE | |
| 551 | PCR EBV QUANTITATIVE | |
| 552 | PCR EGFR (EXON 18 19 20 21) MUTATION | |
| 553 | PCR EGFR (EXON 19) MUTATION | |
| 554 | PCR EGFR (EXON 21) MUTATION | |
| 555 | PCR ENDOMETRIAL CANCER MOLECULAR SUB CLASSIFICATION PANEL | |
| 556 | PCR FACTOR V LEIDEN MUTATION | |
| 557 | PCR FIP1L1 - PDGFRA FUSION DETECTION | |
| 558 | PCR FLT - 3 MUTATION | |
| 559 | PCR FLT-3 (ITD & TKD) MUTATION | |
| 560 | PCR FLT3 AND NPM1 MUTATION | |
| 561 | PCR FLT3-ITD ALLELIC RATIO | |
| 562 | PCR FREIDREICHS ATAXIA MUTATION ANALYSIS | |
| 563 | PCR FUNGAL IDENTIFICATION (CLINICAL SAMPLE) | |
| 564 | PCR GALT MUTATION | |
| 565 | PCR GIST panel (KIT (exon9 11 13 17)/PDGFRA (Exon12 18) | |
| 566 | PCR GONORRHOEAE (Neisseria Gonorrhoeae) | |
| 567 | PCR HBV DNA QUALITATIVE | |
| 568 | PCR HBV DNA QUANTITATIVE (VIRAL LOAD) | |
| 569 | PCR HBV DNA QUANTITATIVE (VIRAL LOAD) - IVD APPROVED | |
| 570 | PCR HBV GENOTYPING | |
| 571 | PCR HCV GENOTYPING | |
| 572 | PCR HCV Quantitative with GENOTYPING | |
| 573 | PCR HCV RNA (QUALITATIVE) | |
| 574 | PCR HCV RNA (QUANTITATIVE) | |
| 575 | PCR Hemophilia - A Inversion panel (Intron 22 & 1) | |
| 576 | PCR Hemophilia A (Intron 1) | |
| 577 | PCR Hemophilia A (Intron 22) | |
| 578 | PCR Hepatitis A Virus (HAV) Detection (Qualitative) | |
| 579 | PCR HFE Gene Mutation (Hereditary hemochromatosis ) | |
| 580 | PCR HHV-6 (Human Herpesvirus 6) Detection - Qualitative | |
| 581 | PCR HHV-7 (Human Herpesvirus 7) Detection - Qualitative | |
| 582 | PCR HIV - I PROVIRAL DNA | |
| 583 | PCR HIV - I QUALITATIVE | |
| 584 | PCR HIV - I QUANTITATIVE (VIRAL LOAD) | |
| 585 | PCR HIV -II QUANTITATIVE (VIRAL LOAD) | |
| 586 | PCR HIV-1 DRUG RESISTANCE | |
| 587 | PCR HLA B | |
| 588 | PCR HLA B*5701 | |
| 589 | PCR HLA B27 | |
| 590 | PCR HLA B51 (BECHETS DISEASE) | |
| 591 | PCR HLA CELIAC DISEASE | |
| 592 | PCR HLA-Cw6(C*06- Psoriatic Arthritis) | |
| 593 | PCR HPV DNA (FFPE BLOCK) | |
| 594 | PCR HPV DNA (LBC) | |
| 595 | PCR HPV SCREENING | |
| 596 | PCR HPV TYPING | |
| 597 | PCR H-RAS MUTATION | |
| 598 | PCR HSV QUALITATIVE | |
| 599 | PCR HSV QUANTITATIVE | |
| 600 | PCR HUNTINGTON DISEASE MUTATION ANALYSIS | |
| 601 | PCR IDH 1/2 MUTATION | |
| 602 | PCR IgVH MUTATION | |
| 603 | PCR JAK 2 PANEL [JAK2V617F & JAK2 EXON 12 MUTATION] | |
| 604 | PCR JAK2 (V617F) MUTATION | |
| 605 | PCR JAK2 EXON 12 MUTATION | |
| 606 | PCR JAK2 REFLEX PANEL ( JAK V617F Negative to EXON 12 Mutation) | |
| 607 | PCR JAPANES ENCEPHALITIS - CSF | |
| 608 | PCR JC VIRUS QUALITATIVE | |
| 609 | PCR KIT gene mutation (exon 9 11 13 17) (Gist/Melanoma) | |
| 610 | PCR K-RAS MUTATION | |
| 611 | PCR LEPTOSPIRA DETECTION | |
| 612 | PCR LPL Panel (MYD88 + CXCR4) | |
| 613 | PCR MALARIA (PLASMODIUM) DETECTION | |
| 614 | PCR MGMT METHYLATION ASSAY | |
| 615 | PCR MICROSATELITE INSTABILITY IN COLON CANCER | |
| 616 | PCR MLL/AF4 t(4:11) | |
| 617 | PCR MPL MUTATION | |
| 618 | PCR MPN Reflex Panel 1 (BCR-ABL1 QL JAK2V617F JAK2 exon 12 CALR MPL) | |
| 619 | PCR MPN Reflex Panel 2 ( JAK2V617F JAK2 exon 12 CALR MPL) | |
| 620 | PCR MPN Reflex Panel 3 ( JAK2V617F CALR MPL) | |
| 621 | PCR MPN SURE PANEL(BCRABL QL JAK2V617F JAK2EX12 MPL CALR) | |
| 622 | PCR MTHFR MUTATION | |
| 623 | PCR MUCORMYCOSIS | |
| 624 | PCR MYD88 GENE MUTATION | |
| 625 | PCR MYOTONIC DYSTROPHY TYPE 1 ( DMPK GENE) | |
| 626 | PCR NARCOLEPSY (HLA DRB1*15 DQB1*06:02 DQA1*01:02) | |
| 627 | PCR NPM-1 MUTATION | |
| 628 | PCR N-RAS MUTATION | |
| 629 | PCR NUDT15 GENOTYPING | |
| 630 | PCR PAI 1 GENOTYPING | |
| 631 | PCR PARVOVIRUS- B 19 - QUALITATIVE | |
| 632 | PCR PARVOVIRUS- B 19 - QUANTITATIVE | |
| 633 | PCR PDGFR MUTATION | |
| 634 | PCR PDGFRA (Exon 12 18) MUTATION | |
| 635 | PCR PIK3CA MUTATION | |
| 636 | PCR PML/RARA t(15;17) - QUALITATIVE | |
| 637 | PCR PML/RARA t(15;17) - QUANTITATIVE | |
| 638 | PCR PMP 22 ( Peripheral Myelin Protein 22) by MLPA | |
| 639 | PCR Pneumocystis Pneumonia (PCP) | |
| 640 | PCR POLE GENE MUTATION ANALYSIS (SEQUENCING) | |
| 641 | PCR PRIMARY CHIMERISM ( PRE TRANSPLANT PATIENT & DONOR) | |
| 642 | PCR PROTHROMBIN MUTATION | |
| 643 | PCR Respiratory pathogen Panel: Multiplex RT-PCR | |
| 644 | PCR RET gene Mutation Testing (EXON - 10 11 13 14 15 16) | |
| 645 | PCR RICKETTSIA DETECTION | |
| 646 | PCR RUBELLA DETECTION | |
| 647 | PCR SALMONELLA DETECTION | |
| 648 | PCR SCA Detection - Single Form | |
| 649 | PCR SMA (SPINAL MUSCULAR ATROPHY) BY MLPA | |
| 650 | PCR SPINAL CEREBRAL ATAXIA ( SCA PANEL 1 2 3 6 7 & 12) | |
| 651 | PCR STD (Sexually Transmitted Diseases) Panel | |
| 652 | PCR T CELL RECEPTOR GENE REARRANGEMENT | |
| 653 | PCR t(8;21)AML-ETO Quantitative Assay | |
| 654 | PCR TB/NTM DETECTION | |
| 655 | PCR TEL/AML1 t(12:21) | |
| 656 | PCR TERT Gene Mutation testing | |
| 657 | PCR Thalassemia complete work-up | |
| 658 | PCR THIOPURINE TOXICITY GENOTYPING (TPMT + NUDT15 GENOTYPING) | |
| 659 | PCR THROMBOPHILIA MUTATION | |
| 660 | PCR TORCH PANEL | |
| 661 | PCR TOXOPLASMA DETECTION | |
| 662 | PCR TP53 GENE MUTATION ANALYSIS | |
| 663 | PCR TPMT GENOTYPING | |
| 664 | PCR Transplant pathogen Mini Panel A | |
| 665 | PCR Transplant pathogen Mini Panel B | |
| 666 | PCR Transplant pathogen Mini Panel C | |
| 667 | PCR Transplant pathogen Mini Panel D | |
| 668 | PCR TRANSPLANT PATHOGEN PANEL (13 Pathogens) | |
| 669 | PCR TROPICAL FEVER PANEL | |
| 670 | PCR UGTIA1 MUTATION | |
| 671 | PCR VARICELLA ZOSTER VIRUS | |
| 672 | PCR VESICULAR RASH PANEL | |
| 673 | PCR VIRAL MENINGITIS - QUALITATIVE | |
| 674 | PCR WARFARIN SENSITIVITY | |
| 675 | PCR WEST NILE VIRUS DETECTION | |
| 676 | PCR Y CHROMOSOME MICRODELETION | |
| 677 | PCR ZIKA VIRUS RNA (QUALITATIVE) | |
| 678 | PCWH syndrome (PCWH) | |
| 679 | PDGFRA mutations | |
| 680 | PDL 1 BY IMMUNOHISTOCHEMISTRY | |
| 681 | Pediatric Hematologic Malignancies Panel - 16 genes | |
| 682 | Pediatric Nervous System/Brain Tumors Panel - 32 genes | |
| 683 | Pediatric Solid Tumors Panel - 47 genes | |
| 684 | Pelizaeus-Merzbacher disease (PMD) | |
| 685 | Pelizaeus-Merzbacher-Like Disease - GJC2 | |
| 686 | PENICILLIUM CHRYSOGENUM - SPECIFIC IGG | |
| 687 | Periodic Fever Syndromes Panel- LPIN2, MEFV, MVK, NLRP3, PST PIP1, TNFRSF1A | |
| 688 | Peripheral Smear Study | |
| 689 | Perlman Syndrome Test - DIS3L2 | |
| 690 | Pesticide (Qualitative) - Gastric Lavage Wadaj | |
| 691 | Peutz-Jeghers Syndrome - STK11 | |
| 692 | PH FOR FLUID | |
| 693 | Phadia - Extended Eczema Panel | |
| 694 | Phadia - Extended Rhinitis/Asthma Panel. | |
| 695 | Phadia - Generalized Comprehensive Panel. | |
| 696 | Phadia - Non Veg. Food Panel | |
| 697 | Phadia - Veg. Food Panel | |
| 698 | Phadia -Comprehensive Food Panel (Veg. And Non Veg | |
| 699 | Phadia-Generalized Comprehensive Panel.(Veg Food) | |
| 700 | Phadiatop Adult Allergy screening | |
| 701 | Phadiatop Infant Allergy Screening | |
| 702 | Phadiatop Infant( <5 Year) IgE | |
| 703 | Phelan-McDermid syndrome | |
| 704 | Phenobarbitone | |
| 705 | PHENOL LEVEL - URINE | |
| 706 | PHENOTHIAZINES (QUALITATIVE) - URINE | |
| 707 | Phenylalanine Quantitative Plasma | |
| 708 | Phenytoin (Eptoin/Epsolin/Dilantin) | |
| 709 | Pheochromocytoma Marker Profile | |
| 710 | Phosphorus | |
| 711 | Phosphorus 24 Hour Urine | |
| 712 | PIGEON SERUM PROTEIN FEATHER & DROPPINGS IGG | |
| 713 | Pitt-Hopkins syndrome (PTHS) | |
| 714 | Pituitary hormone deficiency, combined, 4 (CPHD4) | |
| 715 | PIVKA-II | |
| 716 | PIVKA-II (DCP) | |
| 717 | PLA2 Receptor Ab By Elisa | |
| 718 | PLA2 Receptor Antibody Quantitative | |
| 719 | Plasma Renin Activity | |
| 720 | Platelet Count (Fluorescent) | |
| 721 | Platelet Gp receptor (GpIIb/IIIa and GP Ib) study by flowcytometry | |
| 722 | Platinum | |
| 723 | Pleural Fluid Analysis | |
| 724 | PML/RARA | |
| 725 | PML-RARA Qualitative by Real- time PCR | |
| 726 | PML-RARA Quantification by real-time PCR | |
| 727 | PNEUMO SLIDE PANEL | |
| 728 | Pneumocystis Carinii Detection | |
| 729 | Pneumoslide Panel By IFA IgM | |
| 730 | PNH By Flaer Method | |
| 731 | PNH BY FLOW (FLAER) | |
| 732 | Pompe Disease Test - GAA, LAMP2 | |
| 733 | Porphobilinogen Urine | |
| 734 | Porphyria Profile (Porphobillinogen + ALA) | |
| 735 | Posaconazole Level | |
| 736 | Potassium (K+) | |
| 737 | Potassium 24 Hour Urine | |
| 738 | Potocki-Lupski syndrome (PTLS) | |
| 739 | Potocki-Shaffer syndrome (PSS) | |
| 740 | Prader?Willi syndrome (PWS) | |
| 741 | Prader-Willi/Angelman syndrome Methylation-specific deletion/duplication analysis(MS MLPA) | |
| 742 | Pregnancy Test ( UPT ) | |
| 743 | Pregnenolone | |
| 744 | Pre-implantation genetic screening (1 Embryo) Extended | |
| 745 | Pre-implantation genetic screening (1 Embryo) Stat | |
| 746 | Prenatal DMD (26 exons); with maternal cell contamination analysis | |
| 747 | Prenatal FISH for 13 18 21 X & Y Abnormalities | |
| 748 | PRENATAL KARYOTYPE & FISH | |
| 749 | Prenatal Karyotyping | |
| 750 | Prenatal Karyotyping Product of Conception(POC) | |
| 751 | Prenatal Spinal Muscular Atrophy; with maternal cell contamination analysis | |
| 752 | Primary Ciliary Dyskinesia Panel- 30 genes | |
| 753 | Pro Calcitonin(PCT) | |
| 754 | Product of conception - FISH | |
| 755 | Product of conception - NGS | |
| 756 | Progesterone | |
| 757 | Prolactin | |
| 758 | Propionic Acidemia Panel - PCCA, PCCB | |
| 759 | Prostate Cancer panel - 12 genes | |
| 760 | Protein 24 Hour Urine | |
| 761 | Protein C | |
| 762 | Protein C Deficiency Test - PROC | |
| 763 | Protein Creatinine Ratio | |
| 764 | Protein Electrophoresis | |
| 765 | Protein S Deficiency Test - PROS1 | |
| 766 | Protein S(Free) | |
| 767 | Protein With A/G Ratio | |
| 768 | PS For MP | |
| 769 | PSA (PSA free & PSA Total) | |
| 770 | PSA Total | |
| 771 | PT (Prothrombin Time) | |
| 772 | PT (Prothrombin Time) & APTT (Activated Partial Thromboplastin Time) | |
| 773 | PTH (Parathyroid Hormone) | |
| 774 | PTHrP - PARATHYROID HORMONE RELEATED PEPTIDE | |
| 775 | Pulmonary Arterial Hypertension Panel - ACVRL1, BMPR2, CAV1, ENG,KCNA5, SMAD9 | |
| 776 | Pulmonary hypertension, primary, 1(PPH1) | |
| 777 | PUS Routine Examination | |
| 778 | Pyruvate | |
| 779 | Pyruvate dehydrogenase E1- alpha deficiency (PDHAD) | |
| 780 | Quadruple Marker | |
| 781 | RA Factor | |
| 782 | Rabies Virus Antibodies | |
| 783 | RAS family (KRAS, HRAS, NRAS) | |
| 784 | Rbc Folic Acid | |
| 785 | Recombinant chromosome 8 syndrome | |
| 786 | RECQL4-Related Disorders Test | |
| 787 | REDUCING SUBSTANCES STOOL | |
| 788 | Renal/Urinary Tract Cancer Panel - 29 genes | |
| 789 | Respiratory Syncytial Virus IgA | |
| 790 | RET PTC Rearrangement | |
| 791 | Reticulocyte Count (Automated) | |
| 792 | Retinitis pigmentosa 2 (RP2) | |
| 793 | Retinoblastoma Test - RB1 | |
| 794 | Retinoschisis 1, X-linked, juvenile (RS1) | |
| 795 | Rett and Angelman Syndromes and Related Disorders panel (upto 26 genes) | |
| 796 | RETT syndrome - MECP2 | |
| 797 | Rett syndrome, congenital variant | |
| 798 | Reverse T3 | |
| 799 | RFT- Renal Function Test (Urea, Creatinine, Sodium, Potassium, Chloride) | |
| 800 | Rh Antibody Titre | |
| 801 | Rhabdoid Tumor Predisposition Syndrome Panel - SMARCA4, SMARCB1 | |
| 802 | Riboflavin Transporter Deficiency Neuronopathy panel (2 genes) | |
| 803 | Rifampicin BY HPLC | |
| 804 | Ripa (Ristocetin Induced Platelet Aggregation) | |
| 805 | RNA Sequencing & Analysis on Illumina Platforms (Sample - 35) | |
| 806 | RNA-Seq_DB (RNA-Seq Genome Database) | |
| 807 | ROS-1 | |
| 808 | Rota Virus Stool | |
| 809 | Rota Virus Stool | |
| 810 | RPR (VDRL) | |
| 811 | RUBELLA (GERMAN MEASLES) AVIDITY, IgG | |
| 812 | Rubella IgG | |
| 813 | Rubella IgM | |
| 814 | Rubinstein-Taybi syndrome 1 (RSTS1) | |
| 815 | S.TYPHI IgM by card | |
| 816 | Saethre-Chotzen syndrome (SCS) | |
| 817 | Sandhoff Disease Test- HEXB, HEXA | |
| 818 | Sanger Sequencing (Sample - 44) | |
| 819 | Sanger Sequencing (Sample -41) | |
| 820 | Sanger Sequencing (Sample -45) | |
| 821 | Sanger Sequencing of amplicons (single direction) | |
| 822 | Sarcoma Panel-40 genes | |
| 823 | SBB (Sudan Black B) Stain | |
| 824 | SCA 12 | |
| 825 | SCA 2 | |
| 826 | SCA 3 | |
| 827 | SCA 6 | |
| 828 | Schwannomatosis Test -SMARCB1, NF2 | |
| 829 | SCL-70 Antibody | |
| 830 | SCLERODERMA DIAGNOSIS PANEL | |
| 831 | Scrap Material C/S | |
| 832 | Scrub Typhus IgG by Card | |
| 833 | Scrub Typhus IgM by Card | |
| 834 | SCRUB TYPHUS IgM By Elisa | |
| 835 | Seizures, benign familial neonatal, 1, and/or myokymia | |
| 836 | Selenium Level | |
| 837 | Semen Examination | |
| 838 | Senior-Loken Syndrome Panel - CEP290, IQCB1, NPHP1, NPHP4 | |
| 839 | Serotonin Serum | |
| 840 | SERUM ASCITES ALBUMIN GRADIENT (SAAG) | |
| 841 | Severe Combined Immunodeficiency Panel - 19 genes | |
| 842 | SEX GROWTH HORMONE | |
| 843 | Sex Hormone Binding Globulin (Shbg) | |
| 844 | SGOT | |
| 845 | SGPT | |
| 846 | Short QT Syndrome Panel - CACNA1C, CACNA2D1,)CACNB2, KCNH2, KCNJ2, KCNQ1 | |
| 847 | Sickle Cell Disease (Targeted) - 3 genetic variants | |
| 848 | Sickle Cell Disease (Targeted)- 3 genetic variants; with maternal cell contamination analysis | |
| 849 | Sickling Test | |
| 850 | Simpson-Golabi-Behmel Syndrome Test-GPC3 | |
| 851 | Simpson-Golabi-Behmel syndrome, type 1 (SGBS1) | |
| 852 | Single Mutation Confirmation by Sanger Sequencing | |
| 853 | Sirolimus Level | |
| 854 | Skeletal Function Test | |
| 855 | SKIN DIF(Direct immunofluorescence (DIF) | |
| 856 | SLIDE FOR REVIEW (>20 SLIDES + >20 BLOCKS) | |
| 857 | SLIDE FOR REVIEW (1 SLIDE + 1 BLOCK) | |
| 858 | SLIDE FOR REVIEW (10-15 SLIDES + 10-15 BLOCKS) | |
| 859 | SLIDE FOR REVIEW (16-20 SLIDES + 16-20 BLOCKS) | |
| 860 | SLIDE FOR REVIEW (2 SLIDES + 2 BLOCKS) | |
| 861 | SLIDE FOR REVIEW (3 SLIDES + 3 BLOCKS) | |
| 862 | SLIDE FOR REVIEW (4 to 6 SLIDES + 4 to 6 BLOCKS) | |
| 863 | SLIDE FOR REVIEW (5 SLIDES + 5 BLOCKS) | |
| 864 | SLIDE FOR REVIEW (6 SLIDES + 6 BLOCKS) | |
| 865 | SLIDE FOR REVIEW (7 to 9 SLIDES + 7 to 9 BLOCKS) | |
| 866 | Slit-skin smear examination with Modifiled acid fast stain | |
| 867 | Sm Ab | |
| 868 | Small Cell Carcinoma of the Ovary (Hypercalcemic Type) Test-SMARCA4 | |
| 869 | Small Fiber Neuropathy - SCN9A, SCN10A | |
| 870 | Smith-Lemli-Opitz syndrome (SLOS) | |
| 871 | Smith-Magenis syndrome (SMS) | |
| 872 | SNP-Det08 (SNP Detection in 500 bases) | |
| 873 | Sodium (Na+) | |
| 874 | Sodium 24 Hour Urine | |
| 875 | Sodium Urine | |
| 876 | Soluble Transferrin Receptor sTFR | |
| 877 | Somatic mutation panel 56 genes | |
| 878 | Sotos syndrome 1 (SOTOS1) | |
| 879 | Sotos Syndrome Test - NSD1 | |
| 880 | Speech-language disorder 1 (SPCH1) | |
| 881 | SPERM DNA FRAGMENTATION | |
| 882 | Spermatogenic failure, Y-linked (SPGFY) Panel | |
| 883 | Spinal Muscular Atrophy by MLPA | |
| 884 | Spinal Muscular Atrophy panel (2 genes) | |
| 885 | Split hand/foot malformation (SHFM) Panel | |
| 886 | Sputum For AFB | |
| 887 | SPUTUM FOR CYTOLOGY | |
| 888 | SPUTUM FOR EOSINOPHIL | |
| 889 | Sputum Routine & Micro | |
| 890 | SS-A By ELISA | |
| 891 | Ss-A/Ro (60 Kda 52 Kda) | |
| 892 | Ss-A/Ro (60 Kda) | |
| 893 | SS-B By ELISA | |
| 894 | SS-B/La | |
| 895 | Stem Cell Count(CD-34 Count) | |
| 896 | Sterility Test For Biological Indicator | |
| 897 | Sterility Test For Blood Product | |
| 898 | Sterility Test For Water | |
| 899 | STEROID DETECTION IN UNKNOWN DRUG POWDER | |
| 900 | Stickler Syndrome (STL) Panel | |
| 901 | Stone Analysis | |
| 902 | STONE ANALYSIS BY AUTOMATED MACHINE | |
| 903 | Stool Antigen H.Pylori | |
| 904 | Stool Examination | |
| 905 | Stool Examination For Parasite | |
| 906 | Stool for hanging drop | |
| 907 | Stool For Vibrio Cholera | |
| 908 | Stool Occult Blood | |
| 909 | Streprococcus Pneumoniae (Pneumococcal) Ag Urine | |
| 910 | Streptococcus Pneumoniae Antigen | |
| 911 | STRESS CYTOGENETIC (FANCONI ANEMIA) | |
| 912 | Strongyloidiasis serology Serum by EIA | |
| 913 | STR-Plate12 (Microsatellite Genotyping) | |
| 914 | STR-RRP10 (Microsatellite Genotyping(Ready to run)) | |
| 915 | SUCCINYLACETONE | |
| 916 | Succinylacetone, BLOOD | |
| 917 | Sucrose Lysis Test | |
| 918 | SUDAN III STAIN FOR FAT IN STOOL | |
| 919 | SUDAN IV STAIN STOOL | |
| 920 | SWINE FLU BY PCR | |
| 921 | Syndromic Neurodevelopmental Epilepsy Panel - 16 genes | |
| 922 | Synovial Fluid Gram Z N Stain | |
| 923 | Synovial Fluid Routine Examination | |
| 924 | Synovial Fluid Uric Acid | |
| 925 | Synpolydactyly 1(SPD1) | |
| 926 | Syphilis (Total) Antibodies | |
| 927 | Syphilis Antibody | |
| 928 | SYSTEMIC SCIEROSIS PROFILE | |
| 929 | T3 | |
| 930 | T4 | |
| 931 | Tacrolimus Level | |
| 932 | Tamoxifen sensitivity test (CYP2D6 mutations) | |
| 933 | Tay-Sachs Disease Mutation Analysis - HEXA | |
| 934 | TB Gold | |
| 935 | TB PCR By Gene Expert | |
| 936 | TB PCR FROM BLOCK | |
| 937 | TB PCR FROM TISSUE | |
| 938 | TB PCR-BLOOD | |
| 939 | TB PCR-CSF | |
| 940 | TB PCR-FLUID | |
| 941 | TB PCR-Urine | |
| 942 | TEL/AML1 | |
| 943 | Testosterone | |
| 944 | Tetanus Toxoid IgG antibodies | |
| 945 | TFT- Thyroid Function Test Basic (T3, T4, TSH) | |
| 946 | TFT- Thyroid Function Test Advance (Free T3, Free T4, TSH) | |
| 947 | Thallium By ICPMS | |
| 948 | Theophylline | |
| 949 | Thiopurine Metabolite | |
| 950 | Thrombin Time | |
| 951 | Thrombocytopenia, Paris- Trousseau type (TCPT) | |
| 952 | Thrombocytopenia-absent radius syndrome (TAR) | |
| 953 | Thrombophilia Panel | |
| 954 | Thrombophilia Panel (MTHFR, Factor V and Factor II) by PCR | |
| 955 | Thyroglobulin | |
| 956 | Thyroid Cancer Panel-11 genes | |
| 957 | Thyroid Stimulating Immunoglobulin (Tsi) | |
| 958 | Thyroxine-Binding Globulin (Tbg) Level Serum | |
| 959 | Timothy Syndrome-CACNA1C (exon 1 is not included in deletion/ duplication analysis) | |
| 960 | Tissue processing Block Cutting and staining for 1st Block & Slide | |
| 961 | 2nd Block Cutting and Slide Staining for same patient | |
| 962 | Extra Slide Staining (H & E) | |
| 963 | Grossing charges per sample | |
| 964 | Tissue Transglutaminase TTG- DGP Screen | |
| 965 | T-Lymphocyte Subset Analysis | |
| 966 | TMS - NEWBORN SCREENING FOR METABOLIC DISORDER | |
| 967 | TMS EXTENDED (NEW BORN SCREENING) up to six month | |
| 968 | TNF-ALPHA | |
| 969 | Toe syndactyly, telecanthus, and anogenital and renal malformation | |
| 970 | Tooth agenesis, selective 3 (STHAG3) | |
| 971 | Torch 5 Parameters IgG | |
| 972 | Torch 5 Parameters IgM | |
| 973 | TORCH COMPLEX - 10 PARAMETER (ELISA ) | |
| 974 | TORCH COMPLEX - 8 PARAMETER (ELISA) | |
| 975 | Torch Panel Avidity IgG | |
| 976 | Total Bilirubin | |
| 977 | Total Iron Binding Capacity (TIBC) | |
| 978 | Total Protein Fluid | |
| 979 | Total Protein Serum | |
| 980 | Townes-Brocks syndrome (TBS) | |
| 981 | Townes-Brocks Syndrome Test - SALL1 | |
| 982 | TOXO - IgG | |
| 983 | TOXO - IgM | |
| 984 | TOXOPLASMA AVIDITY, IgG, SERUM | |
| 985 | Toxoplasma DNA Detection, PCR | |
| 986 | TPHA | |
| 987 | TPHA,CSF | |
| 988 | TPMT ENZYME ACTIVITY | |
| 989 | TPMT genotyping | |
| 990 | Transferrin Level | |
| 991 | Transferrin Saturation | |
| 992 | Transplant -DONOR DERIVED CELL FREE DNA ; % dd-cfDNA | |
| 993 | Transplant -HLA TYPING (A B C DRB1 DRB3 4 5 DQAB) | |
| 994 | Transplant -HLA TYPING (A B DRB1) | |
| 995 | Transplant -HLA TYPING FOR PATIENT AND DONOR | |
| 996 | Transplant -HLA TYPING INDIVIDUAL LOCUS (A/B/C/DR/DQ) | |
| 997 | Transplant -LYMPHOCYTE CROSS MATCH REPORT (CDC) | |
| 998 | Transplant -Panel Reactive Antibody Report (PRA) Class I & II Report | |
| 999 | Transplant -SINGLE ANTIGEN SCREEN TEST (SA QUALITATIVE- Class I II & MIC A) | |
| 1000 | Transplant -Single Antigen Quantitative Test Report (Single Antigen Class I & II ) | |
| 1001 | Transplant -T & B CELL FLOW CROSS MATCH (FCXM) REPORT | |
| 1002 | Transthyretin Amyloidosis -TTR | |
| 1003 | Treacher-Collins syndrome 1 (TCS1) | |
| 1004 | Trichorhinophalangeal Syndrome (TRPS) Panel | |
| 1005 | Tricyclic Antidepressants (TCA) | |
| 1006 | Triglyceride | |
| 1007 | Triglyceride Fluid | |
| 1008 | Triglyceride - Urine | |
| 1009 | Triple Marker | |
| 1010 | Triple X syndrome | |
| 1011 | Trisomy 12 | |
| 1012 | Trisomy 8 | |
| 1013 | Troponin - T | |
| 1014 | Troponin I (High Sensitive) by CMIA | |
| 1015 | Troponin I (High Sensitive) by CLIA | |
| 1016 | TRYPTASE | |
| 1017 | TSH | |
| 1018 | TSH Receptor Antibody | |
| 1019 | TTG IgA | |
| 1020 | TTG IgG | |
| 1021 | TTG-DGP SCREEN TEST | |
| 1022 | TUBERCULOSIS CULTURE | |
| 1023 | Tuberous Sclerosis (TSC) Panel | |
| 1024 | Tuberous Sclerosis Complex Panel - TSC1, TSC2 | |
| 1025 | Turner syndrome | |
| 1026 | Type VI Collagenopathy Panel - COL6A1, COL6A2, COL6A3 | |
| 1027 | Typhi DoT by card | |
| 1028 | Typhi Dot IgG | |
| 1029 | Typhi Dot IgM | |
| 1030 | U1rnp (Rnp) Ab | |
| 1031 | U1-snRNP | |
| 1032 | UIBC | |
| 1033 | Ulnar-mammary syndrome (UMS) | |
| 1034 | Unifungal PCR | |
| 1035 | UNISEQ-01 (Purified Plasmid/PCR Product Sequencing Service) | |
| 1036 | UNISEQ-02 (r-E.coli Clone Sequencing Service) | |
| 1037 | Unstable Hb | |
| 1038 | UPT (Urine Pregnancy Test) | |
| 1039 | Urea | |
| 1040 | Urea Clot Lysis Test | |
| 1041 | Urea Cycle Disorders Panel - ALDH18A1, ARG1, ASL, ASS1, CP S1, HMGCL, OATOTC, SLC25A13, SLC25A15 | |
| 1042 | Urea Fluid | |
| 1043 | Urea Nitrogen 24 Hour Urine | |
| 1044 | Uric Acid 24 Hour Urine | |
| 1045 | Uric Acid Serum | |
| 1046 | Uric Acid Urine | |
| 1047 | Urine AFB | |
| 1048 | Urine Albumin | |
| 1049 | URINE AMINO ACID QUANTITATIVE BY LCMS | |
| 1050 | Urine Calcium | |
| 1051 | Urine Calcium Creatine Ratio | |
| 1052 | Urine Chloride | |
| 1053 | Urine Copper (Spot) | |
| 1054 | Urine Cotinine (Nicotine) Level-by card | |
| 1055 | Urine cotinine by HPLC | |
| 1056 | Urine Creatinine (Random) | |
| 1057 | Urine Drug Screen - Amphetamine | |
| 1058 | URINE DRUG SCREEN - Barbiturate | |
| 1059 | Urine Drug Screen - Benzodiazepine | |
| 1060 | URINE DRUG SCREEN - Cocaine/Benzoylecgonine | |
| 1061 | Urine Drug Screen - Marijuana | |
| 1062 | URINE DRUG SCREEN - Methadone | |
| 1063 | URINE DRUG SCREEN - Methamphetamine | |
| 1064 | Urine Drug Screen - Opiates/Morphine | |
| 1065 | URINE DRUG SCREEN - Phencyclidine | |
| 1066 | URINE DRUG SCREEN - Tetra hydro cannabinol | |
| 1067 | Urine Drug Screen (6 Drugs) | |
| 1068 | Urine Drug Screen (9 Drugs) | |
| 1069 | URINE ELECTROLYTES (RANDOM) | |
| 1070 | Urine for Chyluria | |
| 1071 | URINE FOR CYTOLOGY | |
| 1072 | URINE FOR EOSINOPHIL | |
| 1073 | Urine For Fat Globules | |
| 1074 | Urine For Haemoglobinuria | |
| 1075 | URINE FOR HEAVY METALS | |
| 1076 | Urine For Phase Contrast Microscopy | |
| 1077 | URINE FOR PROTEIN ELECTROPHORESIS | |
| 1078 | Urine For Reducing Substances | |
| 1079 | Urine For Specific Gravity | |
| 1080 | Urine Free Light Chain Assay | |
| 1081 | URINE GLUCOSE | |
| 1082 | Urine Hemosiderin | |
| 1083 | Urine Immunofixation | |
| 1084 | URINE KAPPA LIGHT CHAIN | |
| 1085 | URINE MAGNESIUM | |
| 1086 | Urine Myoglobin | |
| 1087 | Urine organic acid | |
| 1088 | Urine Ph | |
| 1089 | Urine Phosphorus(Random) | |
| 1090 | Urine Porphobilinogen Qualitative | |
| 1091 | Urine Porphobillinogen - Quantitative (24 Hour) | |
| 1092 | Urine Porphobillinogen - Quantitative (Spot) | |
| 1093 | Urine Potassium | |
| 1094 | Urine Protein | |
| 1095 | Urine Protein Creatinine Ratio | |
| 1096 | Urine Protein Electrophoresis | |
| 1097 | Urine RBC Morphology By Phase Contrasmicroscopy | |
| 1098 | Urine Routine Examination | |
| 1099 | Urine Uric Acid | |
| 1100 | Urine Uric Acid Creatinine Ratio | |
| 1101 | Urine Urobilinogen | |
| 1102 | Valproic Acid Level (Sodium Valporate) | |
| 1103 | van der Woude syndrome 1 (VWS1) | |
| 1104 | van Der Woude Syndrome Panel -GRHL3, IRF6 | |
| 1105 | Vancomycin | |
| 1106 | VARICELLA ZOSTER IgG | |
| 1107 | VARICELLA ZOSTER IgM | |
| 1108 | VDRL | |
| 1109 | VDRL CSF | |
| 1110 | Velocardiofacial syndrome (VCFS) | |
| 1111 | VGKC Antibody Serum | |
| 1112 | VGKC Antibody, CSF | |
| 1113 | Vitamin A | |
| 1114 | Vitamin B1 | |
| 1115 | Vitamin B12 | |
| 1116 | Vitamin B2 | |
| 1117 | Vitamin B6 (Pyridoxine) | |
| 1118 | Vitamin C | |
| 1119 | Vitamin D | |
| 1120 | Vitamin D Gold (Covers Vitamin D2 Vitamin D3 & D) | |
| 1121 | Vitamin E | |
| 1122 | VITAMIN K | |
| 1123 | Vitamin K1 | |
| 1124 | VITEK CS Blood Aerobic With Vitek Automation | |
| 1125 | VITEK CS CSF with vitek automation | |
| 1126 | VITEK IDENTIFICATION | |
| 1127 | VITEK IDENTIFICATION AND SENSITIVITY | |
| 1128 | VITEK SENSITIVITY | |
| 1129 | VIZAG ONE MARKER | |
| 1130 | VIZAG PDL1(B7H1P) | |
| 1131 | VMA 24 Hour Urine | |
| 1132 | Von Hippel-Lindau Syndrome - VHL by PCR | |
| 1133 | Von Willebrand disease (VWD) -TEST | |
| 1134 | Von Willebrand Factor (VWF) Study | |
| 1135 | Von Willibrand Antigen | |
| 1136 | Voriconazole Level | |
| 1137 | Waardenburg Syndrome (WS) Panel | |
| 1138 | Warfarin sensitivity (CYP2C9, VKORC1) | |
| 1139 | WAS-Related Disorders Test | |
| 1140 | Weak Z N Stain | |
| 1141 | Weaver Syndrome Test - EZH2 | |
| 1142 | Weil Felix Test | |
| 1143 | Werner Syndrome Test - WRN | |
| 1144 | WET MOUNT PREPARATION | |
| 1145 | Whole exome sequencing | |
| 1146 | Widal | |
| 1147 | William syndrome (7q11.23) | |
| 1148 | Williams-Beuren region duplication syndrome | |
| 1149 | Wilms Tumor Panel- DKN1C, DIS3L2, GPC3, WT1 | |
| 1150 | Wilms tumor, aniridia, genitourinary anomalies and | |
| 1151 | Wilson Disease Test - ATP7B | |
| 1152 | Witkop syndrome | |
| 1153 | Wolf-Hirschhorn syndrome | |
| 1154 | Womens Hereditary Cancers (Hereditary Breast and Gynecologic Cancers) -22 genes | |
| 1155 | WT1-Related Disorders Test | |
| 1156 | X, Y FISH Panel | |
| 1157 | XDR TB Rapid Genotyping | |
| 1158 | XDR TB Rapid Genotyping Test 2nd Line (Aminoglycosides/Fluoroquinolones/Capreomycin) | |
| 1159 | XDR TB RAPID GENOTYPING TEST 2ND LINE (AMINOGLYCOSIDES/FLUOROQUINOLONES/CAPREOMYCIN) LPA | |
| 1160 | X-inactivation, familial skewed | |
| 1161 | X-linked ADRENOLEUKODYSTROPHY (X- ALD) | |
| 1162 | Xpert HCV-Viral Load | |
| 1163 | Xpert HIV Viral Load | |
| 1164 | XPERT HIV-1 quantitative viral load with CD4 count | |
| 1165 | XPERT XDR TB | |
| 1166 | Y chromosome microdeletion | |
| 1167 | Yersinia Culture-Stool | |
| 1168 | Yersinia Enterocolitica Antigen- Stool | |
| 1169 | Zika virus Qualitative PCR | |
| 1170 | Zinc Level | |
| 1171 | ZnT8 (ZINC TRANSPORTER 8) ANTIBODY CLIA |
Copyright © 2026 · All Rights Reserved. Terms of Usage | Privacy Policy
For Tender Information Services Visit : TenderDetail